propionyl l-carnitine
Small moleculeexperimental
Clinical trial activity
7 trials · 27 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00399919)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- propionyl l-carnitine
- propionyl l-carnitine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02786043 | Phase 1 | Jun 1, 2015 | Affiliated Hospital of Military Medical Sciences, Lee's Pharmaceutical |
| NCT02786069 | Phase 1 | Jun 1, 2015 | Affiliated Hospital of Military Medical Sciences, Lee's Pharmaceutical |
| NCT01538251 | Phase 3 | Apr 1, 2012 | Leadiant Biosciences, Inc., University of Milan |
| NCT01567956 | Phase 3 | Apr 1, 2012 | Leadiant Biosciences, Inc., Pharmaceutical Research Associates, Inc. (PRA), University of Milan |
| NCT00809497 | Phase 3 | May 1, 2008 | Capital Medical University, Lee's Pharmaceutical, Nanjing Medical University |
| NCT01026857 | Phase 2 | May 1, 2006 | Catholic University of Sacred Heart, Rome, Government of Russia, Kaunas University, Klinika Przewodu Pokarmowego Szpital Kliniczny Nr 1 - Lodz - Poland, Leadiant Biosciences, Inc., Luigi Sacco University Hospital, Samodzielny Publiczny Szpital, University of Naples Frederico II, University of Roma La Sapienza, Vilnius University, Wojewodzki Szpital |
| NCT00399919 | Phase 3 | Apr 1, 2006 | Asheville Cardiology Associates, Baptist Clinical Research, Colorado Prevention Center, Dartmouth University, Department of Veteran Affairs, Jacksonville Center for Clinical Research, Leadiant Biosciences, Inc., Southern Illinois University, University of Massachusetts, University of Rochester, Western Suburban Cardiologists, Ltd. |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (27)
27 organizations
Page 1 / 2